Published in Nat Med on December 01, 1998
The design, synthesis, and evaluation of molecules that enable or enhance cellular uptake: peptoid molecular transporters. Proc Natl Acad Sci U S A (2000) 5.81
Macrophage migration inhibitory factor (MIF) sustains macrophage proinflammatory function by inhibiting p53: regulatory role in the innate immune response. Proc Natl Acad Sci U S A (2001) 3.29
p27Kip1 modulates cell migration through the regulation of RhoA activation. Genes Dev (2004) 3.16
Ability of the hydrophobic FGF and basic TAT peptides to promote cellular uptake of recombinant Cre recombinase: a tool for efficient genetic engineering of mammalian genomes. Proc Natl Acad Sci U S A (2002) 3.01
Twenty years of cell-penetrating peptides: from molecular mechanisms to therapeutics. Br J Pharmacol (2009) 2.99
p27 cytoplasmic localization is regulated by phosphorylation on Ser10 and is not a prerequisite for its proteolysis. EMBO J (2001) 2.45
Protacs: chimeric molecules that target proteins to the Skp1-Cullin-F box complex for ubiquitination and degradation. Proc Natl Acad Sci U S A (2001) 2.39
Targeted pharmaceutical nanocarriers for cancer therapy and imaging. AAPS J (2007) 2.38
Cyclin D1 regulates cellular migration through the inhibition of thrombospondin 1 and ROCK signaling. Mol Cell Biol (2006) 1.95
A specific p47phox -serine phosphorylated by convergent MAPKs mediates neutrophil NADPH oxidase priming at inflammatory sites. J Clin Invest (2006) 1.92
Activation of Rhoa and ROCK are essential for detachment of migrating leukocytes. Mol Biol Cell (2001) 1.88
Novel p27(kip1) C-terminal scatter domain mediates Rac-dependent cell migration independent of cell cycle arrest functions. Mol Cell Biol (2003) 1.85
Reduced infiltration and increased apoptosis of leukocytes at sites of inflammation by systemic administration of a membrane-permeable IkappaBalpha repressor. Arthritis Rheum (2004) 1.79
Differential regulation of retinoblastoma tumor suppressor protein by G(1) cyclin-dependent kinase complexes in vivo. Mol Cell Biol (2001) 1.78
Striatin assembles a membrane signaling complex necessary for rapid, nongenomic activation of endothelial NO synthase by estrogen receptor alpha. Proc Natl Acad Sci U S A (2004) 1.77
p27: a barometer of signaling deregulation and potential predictor of response to targeted therapies. Clin Cancer Res (2010) 1.74
Selective killing of transformed cells by cyclin/cyclin-dependent kinase 2 antagonists. Proc Natl Acad Sci U S A (1999) 1.67
Blockade of inflammation and airway hyperresponsiveness in immune-sensitized mice by dominant-negative phosphoinositide 3-kinase-TAT. J Exp Med (2003) 1.64
Cholesterol binding at the cholesterol recognition/ interaction amino acid consensus (CRAC) of the peripheral-type benzodiazepine receptor and inhibition of steroidogenesis by an HIV TAT-CRAC peptide. Proc Natl Acad Sci U S A (2001) 1.57
Histone acetyltransferase activity of p300 is required for transcriptional repression by the promyelocytic leukemia zinc finger protein. Mol Cell Biol (2005) 1.52
Role of reactive oxygen species in the progression of type 2 diabetes and atherosclerosis. Mediators Inflamm (2010) 1.49
123I-labeled HIV-1 tat peptide radioimmunoconjugates are imported into the nucleus of human breast cancer cells and functionally interact in vitro and in vivo with the cyclin-dependent kinase inhibitor, p21(WAF-1/Cip-1). Eur J Nucl Med Mol Imaging (2006) 1.48
RSK1 drives p27Kip1 phosphorylation at T198 to promote RhoA inhibition and increase cell motility. Proc Natl Acad Sci U S A (2009) 1.46
High throughput selection of effective serodiagnostics for Trypanosoma cruzi infection. PLoS Negl Trop Dis (2008) 1.46
Scaffolding of Fyn kinase to the NMDA receptor determines brain region sensitivity to ethanol. J Neurosci (2003) 1.44
B cells "transduced" with TAT-fusion proteins can induce tolerance and protect mice from diabetes and EAE. Clin Immunol (2011) 1.44
Cell entry of arginine-rich peptides is independent of endocytosis. J Biol Chem (2008) 1.41
Improving the endosomal escape of cell-penetrating peptides and their cargos: strategies and challenges. Pharmaceuticals (Basel) (2012) 1.32
IL-4 abrogates osteoclastogenesis through STAT6-dependent inhibition of NF-kappaB. J Clin Invest (2001) 1.31
MUC1 and metastatic cancer: expression, function and therapeutic targeting. Cell Adh Migr (2013) 1.31
The taming of the cell penetrating domain of the HIV Tat: myths and realities. J Control Release (2006) 1.30
Nanos functions to maintain the fate of the small micromere lineage in the sea urchin embryo. Dev Biol (2009) 1.29
NFATc1 regulation of the human beta3 integrin promoter in osteoclast differentiation. Gene (2006) 1.28
Phosphorylation of p27Kip1 regulates assembly and activation of cyclin D1-Cdk4. Mol Cell Biol (2008) 1.27
Arsenite-induced Cdc25C degradation is through the KEN-box and ubiquitin-proteasome pathway. Proc Natl Acad Sci U S A (2002) 1.26
Control of siRNA expression using the Cre-loxP recombination system. Nucleic Acids Res (2004) 1.24
Commitment point during G0-->G1 that controls entry into the cell cycle. Mol Cell Biol (2003) 1.21
Cargo-dependent cytotoxicity and delivery efficacy of cell-penetrating peptides: a comparative study. Biochem J (2007) 1.20
p21cip1 is required for the differentiation of oligodendrocytes independently of cell cycle withdrawal. EMBO Rep (2001) 1.20
PTPH1 dephosphorylates and cooperates with p38gamma MAPK to increase ras oncogenesis through PDZ-mediated interaction. Cancer Res (2010) 1.18
Peroxiredoxin 6 delivery attenuates TNF-alpha-and glutamate-induced retinal ganglion cell death by limiting ROS levels and maintaining Ca2+ homeostasis. Brain Res (2008) 1.16
Inhibition of multiple subtypes of influenza A virus in cell cultures with morpholino oligomers. Antimicrob Agents Chemother (2006) 1.16
Suppression of immunoglobulin E-mediated allergic responses by regulator of G protein signaling 13. Nat Immunol (2007) 1.14
Mechanism of dietary salt-mediated increase in intravascular production of TGF-beta1. Am J Physiol Renal Physiol (2008) 1.13
Forkhead box F1 is essential for migration of mesenchymal cells and directly induces integrin-beta3 expression. Mol Cell Biol (2007) 1.12
Protection against ischemic brain injury by protein therapeutics. Proc Natl Acad Sci U S A (2002) 1.11
Peptide blockade of HIFalpha degradation modulates cellular metabolism and angiogenesis. Proc Natl Acad Sci U S A (2002) 1.11
Itk controls the spatiotemporal organization of T cell activation. Sci Signal (2011) 1.11
Peptides in cancer nanomedicine: drug carriers, targeting ligands and protease substrates. J Control Release (2011) 1.09
Transforming growth factor beta targeted inactivation of cyclin E:cyclin-dependent kinase 2 (Cdk2) complexes by inhibition of Cdk2 activating kinase activity. Proc Natl Acad Sci U S A (1999) 1.09
Biological applications of protein transduction technology. Trends Biotechnol (2003) 1.07
Novel genetic tools reveal Cdk5's major role in Golgi fragmentation in Alzheimer's disease. Mol Biol Cell (2008) 1.07
Transduction of the scorpion toxin maurocalcine into cells. Evidence that the toxin crosses the plasma membrane. J Biol Chem (2005) 1.06
Unmodified Cre recombinase crosses the membrane. Nucleic Acids Res (2002) 1.04
Cytoplasmic p27 promotes epithelial-mesenchymal transition and tumor metastasis via STAT3-mediated Twist1 upregulation. Oncogene (2015) 1.04
HIV-associated disruption of mucosal epithelium facilitates paracellular penetration by human papillomavirus. Virology (2013) 1.04
The neurofibromatosis type 2 gene product, merlin, reverses the F-actin cytoskeletal defects in primary human Schwannoma cells. Mol Cell Biol (2002) 1.04
Transduction of the cytoplasmic domain of CTLA-4 inhibits TcR-specific activation signals and prevents collagen-induced arthritis. Proc Natl Acad Sci U S A (2008) 1.03
TAT-mediated intracellular delivery of purine nucleoside phosphorylase corrects its deficiency in mice. J Clin Invest (2006) 1.03
Comparative study on transduction and toxicity of protein transduction domains. Br J Pharmacol (2008) 1.02
Regulation of the ubiquitin-conjugating enzyme hHR6A by CDK-mediated phosphorylation. EMBO J (2002) 1.02
Involvement of oxidative stress and the JNK pathway in glucose toxicity. Rev Diabet Stud (2005) 1.01
Protective effects of anti-ricin A-chain antibodies delivered intracellularly against ricin-induced cytotoxicity. World J Biol Chem (2010) 0.99
Cell cycle, cytoskeleton dynamics and beyond: the many functions of cyclins and CDK inhibitors. Cell Cycle (2015) 0.98
PRDX6 attenuates oxidative stress- and TGFbeta-induced abnormalities of human trabecular meshwork cells. Free Radic Res (2009) 0.98
Repair of a minimal DNA double-strand break by NHEJ requires DNA-PKcs and is controlled by the ATM/ATR checkpoint. Nucleic Acids Res (2003) 0.98
Mutations of the Listeria monocytogenes peptidoglycan N-deacetylase and O-acetylase result in enhanced lysozyme sensitivity, bacteriolysis, and hyperinduction of innate immune pathways. Infect Immun (2011) 0.98
Metabolic cleavage of cell-penetrating peptides in contact with epithelial models: human calcitonin (hCT)-derived peptides, Tat(47-57) and penetratin(43-58). Biochem J (2004) 0.98
Inhibitors of alpha-synuclein oligomerization and toxicity: a future therapeutic strategy for Parkinson's disease and related disorders. Exp Brain Res (2006) 0.98
Fusion of HIV-1 Tat protein transduction domain to poly-lysine as a new DNA delivery tool. Br J Cancer (2004) 0.98
Lipid binding activities of flax rust AvrM and AvrL567 effectors. Plant Signal Behav (2010) 0.97
Curb challenges of the "Trojan Horse" approach: smart strategies in achieving effective yet safe cell-penetrating peptide-based drug delivery. Adv Drug Deliv Rev (2013) 0.97
Cell-free production of transducible transcription factors for nuclear reprogramming. Biotechnol Bioeng (2009) 0.96
Tumour lineage-homing cell-penetrating peptides as anticancer molecular delivery systems. Nat Commun (2012) 0.96
Design of peptide-based inhibitors for human immunodeficiency virus type 1 strains resistant to T-20. J Biol Chem (2008) 0.96
Heparin binding by the HIV-1 tat protein transduction domain. Protein Sci (2001) 0.96
Induction of melanoma cell apoptosis and inhibition of tumor growth using a cell-permeable Survivin antagonist. Oncogene (2006) 0.95
Failure of gamma interferon but not interleukin-10 expression in response to human papillomavirus type 11 E6 protein in respiratory papillomatosis. Clin Diagn Lab Immunol (2004) 0.95
Protein expression profiling of lens epithelial cells from Prdx6-depleted mice and their vulnerability to UV radiation exposure. Am J Physiol Cell Physiol (2009) 0.95
Distinct and nonoverlapping roles for pRB and cyclin D:cyclin-dependent kinases 4/6 activity in melanocyte survival. Proc Natl Acad Sci U S A (2003) 0.95
Nkx3.1 binds and negatively regulates the transcriptional activity of Sp-family members in prostate-derived cells. Biochem J (2006) 0.95
Transduction of artificial transcriptional regulatory proteins into human cells. Nucleic Acids Res (2008) 0.95
HAP2(GCS1)-dependent gamete fusion requires a positively charged carboxy-terminal domain. PLoS Genet (2010) 0.94
External control of Her2 expression and cancer cell growth by targeting a Ras-linked coactivator. Proc Natl Acad Sci U S A (2002) 0.94
SNAP-23 and syntaxin-2 localize to the extracellular surface of the platelet plasma membrane. Blood (2007) 0.94
TAT-mediated transduction of NF-Ya peptide induces the ex vivo proliferation and engraftment potential of human hematopoietic progenitor cells. Blood (2010) 0.93
Histamine-releasing factor has a proinflammatory role in mouse models of asthma and allergy. J Clin Invest (2011) 0.93
Mammary epithelial cell-cycle progression via the alpha(2)beta(1) integrin: unique and synergistic roles of the alpha(2) cytoplasmic domain. Am J Pathol (2001) 0.91
H-Ras modulates N-methyl-D-aspartate receptor function via inhibition of Src tyrosine kinase activity. J Biol Chem (2003) 0.91
Nanopreparations for organelle-specific delivery in cancer. Adv Drug Deliv Rev (2013) 0.90
Defects in retinal pigment epithelium cell proliferation and retinal attachment in mutant mice with p27(Kip1) gene ablation. Mol Vis (2007) 0.90
The role of synaptotagmin I C2A calcium-binding domain in synaptic vesicle clustering during synapse formation. J Physiol (2007) 0.90
Non-canonical functions of cell cycle cyclins and cyclin-dependent kinases. Nat Rev Mol Cell Biol (2016) 0.90
Single particle tracking confirms that multivalent Tat protein transduction domain-induced heparan sulfate proteoglycan cross-linkage activates Rac1 for internalization. J Biol Chem (2011) 0.89
Excision of HIV-1 proviral DNA by recombinant cell permeable tre-recombinase. PLoS One (2012) 0.89
Creation of a bi-directional protein transduction system for suppression of HIV-1 expression by p27SJ. Antiviral Res (2007) 0.89
RGS16 attenuates pulmonary Th2/Th17 inflammatory responses. J Immunol (2012) 0.89
Exploring transduction mechanisms of protein transduction domains (PTDs) in living cells utilizing single-quantum dot tracking (SQT) technology. Sensors (Basel) (2012) 0.88
Direct and indirect roles of cyclin-dependent kinase 5 as an upstream regulator in the c-Jun NH2-terminal kinase cascade: relevance to neurotoxic insults in Alzheimer's disease. Mol Biol Cell (2009) 0.87
In vivo protein transduction: delivery of a biologically active protein into the mouse. Science (1999) 10.70
TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling. Genes Dev (1999) 6.93
High cancer susceptibility and embryonic lethality associated with mutation of the PTEN tumor suppressor gene in mice. Curr Biol (1998) 6.38
ICOS is essential for effective T-helper-cell responses. Nature (2001) 4.01
Digital indocyanine green videoangiography of central serous chorioretinopathy. Arch Ophthalmol (1994) 3.44
Function of a human cyclin gene as an oncogene. Proc Natl Acad Sci U S A (1994) 2.87
TAT-mediated protein transduction into mammalian cells. Methods (2001) 2.64
Less mortality but more relapses in experimental allergic encephalomyelitis in CD8-/- mice. Science (1992) 2.60
Synthetic protein transduction domains: enhanced transduction potential in vitro and in vivo. Cancer Res (2001) 2.54
Cyclin D1 stimulation of estrogen receptor transcriptional activity independent of cdk4. Mol Cell Biol (1997) 2.40
Protein transduction: unrestricted delivery into all cells? Trends Cell Biol (2000) 2.37
In vivo protein transduction: intracellular delivery of biologically active proteins, compounds and DNA. Trends Pharmacol Sci (2000) 2.35
Hospitalised adult patients with Suspected 2009 H1N1 Infection at Regional Infectious Diseases Units in Scotland--most had alternative final diagnoses. J Infect (2009) 2.24
Current status of solvent/detergent-treated frozen plasma. Transfusion (1998) 2.24
Brca2 is required for embryonic cellular proliferation in the mouse. Genes Dev (1997) 2.20
A common E2F-1 and p73 pathway mediates cell death induced by TCR activation. Nature (2000) 2.10
Hypophosphatemic rickets with hypocalciuria following long-term treatment with aluminum-containing antacid. Bone (1991) 2.06
Colorectal carcinomas in mice lacking the catalytic subunit of PI(3)Kgamma. Nature (2000) 1.93
Embryonic-fetal erythroid characteristics of a human leukemic cell line. Proc Natl Acad Sci U S A (1980) 1.90
CDKN2B methylation status and isolated chromosome 7 abnormalities predict responses to treatment with 5-azacytidine. Leukemia (2007) 1.79
Differential regulation of retinoblastoma tumor suppressor protein by G(1) cyclin-dependent kinase complexes in vivo. Mol Cell Biol (2001) 1.78
Rho-A is critical for osteoclast podosome organization, motility, and bone resorption. J Biol Chem (2000) 1.69
The retinoblastoma protein and the regulation of cell cycling. Trends Biochem Sci (1992) 1.68
Hypo-phosphorylation of the retinoblastoma protein (pRb) by cyclin D:Cdk4/6 complexes results in active pRb. Proc Natl Acad Sci U S A (1997) 1.67
Killing HIV-infected cells by transduction with an HIV protease-activated caspase-3 protein. Nat Med (1999) 1.63
Collagen-induced arthritis in TNF receptor-1-deficient mice: TNF receptor-2 can modulate arthritis in the absence of TNF receptor-1. Clin Immunol (2001) 1.59
Biological methods for cell-cycle synchronization of mammalian cells. Biotechniques (2001) 1.57
Predictable individual differences in the initiation of cocaine self-administration by rats under extended-access conditions are dose-dependent. Psychopharmacology (Berl) (2001) 1.53
Non-infectious complications of transfusion therapy. Blood Rev (2001) 1.47
Prevalence of sleep-disordered breathing in diastolic heart failure. Chest (1997) 1.47
Transforming activity and mitosis-related expression of the AKT2 oncogene: evidence suggesting a link between cell cycle regulation and oncogenesis. Oncogene (1997) 1.46
Interleukin 13 is secreted by and stimulates the growth of Hodgkin and Reed-Sternberg cells. J Exp Med (1999) 1.44
Removal of Yersinia enterocolitica from AS-1 red cells. Transfusion (1992) 1.43
Transduced p16INK4a peptides inhibit hypophosphorylation of the retinoblastoma protein and cell cycle progression prior to activation of Cdk2 complexes in late G1. Cancer Res (1999) 1.38
Role of Escherichia coli rpoS and associated genes in defense against oxidative damage. Free Radic Biol Med (1996) 1.38
Major histocompatibility proteins, anti-Hu antibodies, and paraneoplastic encephalomyelitis in neuroblastoma and small cell lung cancer. Cancer (1995) 1.36
Cytokine generation in stored platelet concentrates. Transfusion (1994) 1.35
Rho family GTPases regulate VEGF-stimulated endothelial cell motility. Exp Cell Res (2001) 1.33
Beyond informed consent: the therapeutic misconception and trust. J Med Ethics (2008) 1.32
Murine lupus in MRL/lpr mice lacking CD4 or CD8 T cells. Eur J Immunol (1995) 1.26
Genotype patterns that contribute to increased risk for or protection from developing heroin addiction. Mol Psychiatry (2008) 1.25
Prevalence of asthma and allergy in Hong Kong schoolchildren: an ISAAC study. Eur Respir J (1997) 1.24
hADA3 is required for p53 activity. EMBO J (2001) 1.22
Longitudinal study of predictive factors for periodontal disease and tooth loss. J Clin Periodontol (1999) 1.22
Reduced incidence and severity of antigen-induced autoimmune diseases in mice lacking interferon regulatory factor-1. J Exp Med (1997) 1.22
Comparison of the ISAAC video questionnaire (AVQ3.0) with the ISAAC written questionnaire for estimating asthma associated with bronchial hyperreactivity. Clin Exp Allergy (1997) 1.20
p21cip1 is required for the differentiation of oligodendrocytes independently of cell cycle withdrawal. EMBO Rep (2001) 1.20
Collagen-induced arthritis in CD4- or CD8-deficient mice: CD8+ T cells play a role in initiation and regulate recovery phase of collagen-induced arthritis. J Immunol (1996) 1.17
Transduction of full-length Tat fusion proteins directly into mammalian cells: analysis of T cell receptor activation-induced cell death. Methods Enzymol (2000) 1.16
Peripheral light focusing by the anterior eye and the ophthalmohelioses. Ophthalmic Surg (1991) 1.15
Occurrence of the release reaction during preparation and storage of platelet concentrates. Vox Sang (1981) 1.14
Corticotropin-releasing factor and type 1 corticotropin-releasing factor receptor messenger RNAs in rat brain and pituitary during "binge"-pattern cocaine administration and chronic withdrawal. J Pharmacol Exp Ther (1996) 1.14
CD28-deficient mice are highly resistant to collagen-induced arthritis. J Immunol (1999) 1.13
Pathogen inactivation techniques. Best Pract Res Clin Haematol (2006) 1.12
Purified JC virus T and T' proteins differentially interact with the retinoblastoma family of tumor suppressor proteins. Virology (2000) 1.11
Identification of a human immunodeficiency virus type 2 (HIV-2) encapsidation determinant and transduction of nondividing human cells by HIV-2-based lentivirus vectors. J Virol (1998) 1.10
Cocaine self-administration in mice is inversely related to phosphorylation at Thr34 (protein kinase A site) and Ser130 (kinase CK1 site) of DARPP-32. J Neurosci (2006) 1.09
Television advertising and drug use. Am J Public Health (1976) 1.09
Transforming growth factor beta targeted inactivation of cyclin E:cyclin-dependent kinase 2 (Cdk2) complexes by inhibition of Cdk2 activating kinase activity. Proc Natl Acad Sci U S A (1999) 1.09
Patient history in screening for dry eye conditions. J Am Optom Assoc (1987) 1.08
Altered HPA axis responsivity to metyrapone testing in methadone maintained former heroin addicts with ongoing cocaine addiction. Neuropsychopharmacology (2001) 1.08
TAT fusion proteins containing tyrosine 42-deleted IkappaBalpha arrest osteoclastogenesis. J Biol Chem (2001) 1.08
Electrotonic parameters of rat dentate granule cells measured using short current pulses and HRP staining. J Neurophysiol (1983) 1.08
Impact of pretransplant comorbidities on alemtuzumab-based reduced-intensity conditioning allogeneic hematopoietic SCT for patients with high-risk myelodysplastic syndrome and AML. Bone Marrow Transplant (2009) 1.07
Swallow induces a peristaltic wave of distension that marches in front of the peristaltic wave of contraction. Neurogastroenterol Motil (2010) 1.07
Time course of the development of behavioral sensitization and dopamine receptor up-regulation during binge cocaine administration. J Pharmacol Exp Ther (1994) 1.06
Composite tissue (limb) allografts in rats. III. Development of donor-host lymphoid chimeras in long-term survivors. Transplantation (1986) 1.06
Neuroendocrine alterations in a high-dose, extended-access rat self-administration model of escalating cocaine use. Psychoneuroendocrinology (2003) 1.05
Two-dimensional gel electrophoresis and immunoblotting of Campylobacter outer membrane proteins. Infect Immun (1987) 1.05
Estrous cycle differences in cocaine-induced stereotypic and locomotor behaviors in Fischer rats. Behav Brain Res (1999) 1.05
Nonlinear combination of luminance excursions during flicker, simultaneous contrast, afterimages and binocular fusion. Vision Res (1998) 1.05
CD28 costimulation is crucial for the development of spontaneous autoimmune encephalomyelitis. J Immunol (1999) 1.04
Quality-adjusted life years: population-specific measurement of the quality component. Hong Kong Med J (2011) 1.04
Effects of cocaine self-administration on plasma corticosterone and prolactin in rats. J Pharmacol Exp Ther (2000) 1.04
TCR antigen-induced cell death occurs from a late G1 phase cell cycle check point. Immunity (1998) 1.03
Color Doppler imaging: a new technique to assess orbital blood flow in patients with diabetic retinopathy. Invest Ophthalmol Vis Sci (1995) 1.03
Optimum dry eye classification using questionnaire responses. Adv Exp Med Biol (1998) 1.02
Chronic administration of a cocaine "binge" alters basal extracellular levels in male rats: an in vivo microdialysis study. J Pharmacol Exp Ther (1995) 1.02
Effects of "binge" pattern cocaine on stereotypy and locomotor activity in C57BL/6J and 129/J mice. Pharmacol Biochem Behav (1998) 1.02
Influence of corneal shape on limbal light focusing. Invest Ophthalmol Vis Sci (1994) 1.01
Purification and properties of an intracellular calmodulinlike protein from Bacillus subtilis cells. J Bacteriol (1991) 1.01
Toward an analogue of alcoholism in mice: criteria for recognition of pharmacologically motivated drinking. Proc Natl Acad Sci U S A (1985) 1.00
Comparative study of antipneumocystis agents in rats by using a Pneumocystis carinii-specific DNA probe to quantitate infection. J Clin Microbiol (1992) 1.00
Senile cardiac amyloidosis associated with homozygosity for a transthyretin variant (ILE-122). J Lab Clin Med (1991) 1.00
Protein/peptide transduction domains: potential to deliver large DNA molecules into cells. Curr Opin Mol Ther (2001) 1.00
Methadone-maintained former heroin addicts, including those who are anti-HIV-1 seropositive, comply with and respond to hepatitis B vaccination. Addiction (1999) 0.99